Amino Acid Connected to Fatty Liver Disease Could Provide Treatment Clues

Basic science research explores the effects of impaired glycine metabolism in nonalcoholic fatty liver disease and how to potentially use glycine-based treatment to help people with NAFLD.

8:48 AM

Author | Haley Otman

drawing of liver on lined paper in blue ink with a yellow badge with blue font on bottom right that says lab note

A new study further implicates low levels of the amino acid glycine in development of nonalcoholic fatty liver disease, or NAFLD. It also suggests addressing this might hold the key to a future treatment for the disease.

"We've uncovered a new metabolic pathway and potential novel treatment," says senior author Y. Eugene Chen, M.D., Ph.D., a professor of internal medicine, cardiac surgery, physiology, pharmacology and medicinal chemistry, from the Michigan Medicine Frankel Cardiovascular Center. His team collaborated with researchers from the University of Michigan, Wayne State University and Technion-Israel Institute of Technology.

Chen says there is a large need to expand treatment options for patients with NAFLD. Although it's the most common chronic liver disease, there are currently no approved drugs to treat it.

Lead author Oren Rom, Ph.D., R.D., a research fellow at the Michigan Medicine Frankel Cardiovascular Center, says the team focused on the poorly understood relationship between dysregulated amino acid metabolism and NAFLD.

"In particular, lower circulating glycine is consistently reported in patients with NAFLD and related comorbidities including diabetes, obesity and cardiovascular diseases," Rom says. "Our studies not only offer a metabolic explanation for defective glycine metabolism in NAFLD, but also uncover a potential glycine-based treatment." 

The researchers were able to improve body composition and several other measures in mouse models using a tripeptide known as DT-109.

"Glycine-based treatment attenuates experimental NAFLD by stimulating hepatic fatty acid oxidation and glutathione synthesis, thus warranting clinical evaluation," the authors write.

Paper cited: "Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome," Science Translational Medicine. DOI: 10.1126/scitranslmed.aaz2841

Disclosure: Chen is an inventor of the compound DT-109. The University of Michigan has patented it and licensed it to Diapin Therapeutics. Chen and the university have an ownership interest in Diapin. The company is further developing the compound.


More Articles About: Lab Notes Nonalcoholic fatty liver disease (NAFLD) Basic Science and Laboratory Research Liver Conditions & Procedures
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories blood vessel up close with red cells and yellow inside
Health Lab
Drug candidate successfully treats atherosclerosis, fatty liver disease in large mammals 
A compound that was previously found to treat severe fatty liver disease also reduces atherosclerosis, a primary driver of cardiovascular death, in non-human primates. The drug candidate was developed at the University of Michigan.
drawing on orange background of colorful pills floating with body parts in them in pain
Health Lab
Cerebral palsy medications given to adults may not match needs
Prescribing medications that treat the most obvious parts of adult cerebral palsy pain and symptoms without examining for the underlying cause is a common experience for adults with cerebral palsy. This means that proper treatment is being overlooked and these medications can cause further complications later in life.
nurse in maroon at patient bedside
Health Lab
Studying interventions to help type 2 diabetes patients avoid hospitalizations
Research from University of Michigan will be looking at the way social determinants of health can have an impact on the health of people living with type 2 diabetes.
pointing to worm on screen
Health Lab
Planarian worms can regenerate into a more youthful version of themselves
Study finds planarian worms can regenerate into a more youthful version of themselves.
sperm moving to cell all blue and cell red
Health Lab
Battle of the sex chromosomes
A study from University of Michigan researchers has uncovered the mechanism behind the arms race for mouse X and Y bearing sperm to fertilize an egg.
hands up in to sun blocking it in shadowy area under tree
Health Lab
Decoding mechanisms of photosensitivity in autoimmune diseases
Photosensitivity is a common occurrence in patients with autoimmune disorders, especially lupus and dermatomyositis. The only treatment for this currently is diligent sunscreen use, but research is leading to new insights in how photosensitivity is created on a cellular level.